Morphine Sulphate Wockhardt Uk (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morphine Sulphate Wockhardt Uk, is an opioid analgesic presented as a sterile injectable solution for intramuscular, intravenous, and subcutaneous use. It treats severe acute pain, postoperative pain and cancer pain in adult patients. GNH USA supplies Morphine Sulphate Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Morphine Sulfate is an opioid analgesic used to manage pain pathways in several clinical settings. - Severe acute pain: provides rapid relief of intense pain following injury or trauma. - Postoperative pain: controls pain after surgical procedures to facilitate recovery. - Cancer pain: alleviates persistent malignant pain in patients receiving palliative care.

Morphine Sulfate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset occurring shortly after administration. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness or sedation: increased sleepiness and reduced alertness. - Pruritus: itching, often localized.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure, especially with rapid IV bolus. - Anaphylaxis or severe allergic reaction: rare but may include rash, swelling, and airway compromise.

Morphine Sulfate requires careful clinical monitoring and patient assessment before and during therapy. - Assess pain level: determine baseline pain intensity and response to treatment. - Monitor respiratory function: watch for signs of respiratory depression, especially after dose changes. - Adjust dose in renal or hepatic impairment: reduce dosage or increase dosing interval as needed. - Use caution in elderly patients: increased sensitivity to sedative effects. - Avoid concomitant use with MAO inhibitors: risk of severe hypertension or serotonin syndrome. - Store at controlled room temperature: keep in the original container, protect from moisture and light.

Morphine Sulfate can interact with other medicines, altering its effect or increasing risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis or serotonin syndrome. - Central nervous system depressants (e.g., benzodiazepines, barbiturates): potentiate respiratory depression. - Respiratory depressants (e.g., general anesthetics): increase risk of life‑threatening hypoventilation.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise morphine plasma levels. - Diuretics: can enhance hypotensive effects. - Antihistamines: may increase sedation and dizziness.